Novel Reimbursement Approaches: Overcoming Barriers

2:00 PM - 2:45 PM (EDT), Thursday, June 17, 2021
Search General Info
Search Education
Search Partnering Companies

Current Federal and State reimbursement systems are not nimble enough to accommodate the pace of innovation causing structural harm to the very populations who need these services most.  While “innovative payment models” and “value based arrangements” are buzzy terms, they don’t address the current problem of Medicare and Medicaid patients not having timely access to novel therapies.  This panel will bring together different perspectives showing real examples of the barriers that still exist. 

VP, Government Affairs & Policy
Iovance Biotherapeutics
Chief External Affairs Officer
National Hemophilia Foundation
Head of US Market Access
CSL Behring